Aquinox Pharma Revenue, Profits - AQXP Annual Income Statement

Add to My Stocks
$14.28 $0.14 (0.97%) AQXP stock closing price Mar 20, 2018 (Closing)

Looking at financial statements, along with the Aquinox Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. Like any other income statement, the AQXP income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. The Aquinox Pharma profit and loss statement for 2016 shows a net profit of $-37M. Profits for last year was $-21.86M. Apart from this an investor should also check Aquinox Pharma assets and Aquinox Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20162015201420132012
Aquinox Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)-----
Aquinox Pharma Gross Profit
Research & Development Expense28.38M15.79M18.07M7.53M5.91M
Selling General & Admin Expense9.26M5.54M4.29M1.77M1.63M
Income Before Depreciation Depletion Amortization-37.64M-21.34M-22.37M-9.31M-7.55M
Depreciation Depletion Amortization-----
Non Operating Income--0.42M-1.65M--
Interest Expense-----
Aquinox Pharma Pretax Income
Provision for Income Taxes----0.01M-
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-37M-21.86M-24.02M-8.72M-7.71M
Extraordinary Items & Discontinued Operations-----
Aquinox Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS18.89M12.64M8.67M5.85M4.12M
Average Shares used to compute Basic EPS18.89M12.64M8.67M5.85M4.12M
Income Before Nonrecurring Items-37M-21.86M-24.03M-8.73M-7.71M
Income from Nonrecurring Items-----
Aquinox Pharma Earnings Per Share Basic Net
Aquinox Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-1.96-1.73-2.75-1.59-1.86
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Aquinox Pharma stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that AQXP stock has a topline or revenue of $- for 2016 as per this Aquinox Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. AQXP stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the AQXP income statement, one can check the Aquinox Pharma historical stock prices to check how the price has moved with time.

Aquinox Pharma Income Statement - Key Financial Ratios